Neuro-Oncology: The Podcast

99 Folgen

1. Molecular signatures of glioma causation

   Vom: 6.8.2021
2. Testing methods for MGMT promoter methylation

   Vom: 23.7.2021
3. Temozolomide-induced hypermutation in IDH-mutant low-grade gliomas

   Vom: 9.7.2021
4. Posterior fossa syndrome

   Vom: 18.6.2021
5. Loss of H3K27me3 in meningiomas

   Vom: 4.6.2021
6. Loss of H3K27me3 in the Tübingen meningioma cohort

   Vom: 21.5.2021
7. A prospective phase II randomized trial of proton radiotherapy vs intensity modulated radiotherapy for patients with newly diagnosed GBM

   Vom: 7.5.2021
8. Brain radiotherapy and decline in fine motor skills

   Vom: 9.4.2021
9. A serum based DNA methylation assay to detect gliomas

   Vom: 26.3.2021
10. PTEN deficiency and proteosome addiction in glioblastoma

    Vom: 12.3.2021
11. Cold-Inducible RNA-Binding Protein expression and recurrence of brain metastases

    Vom: 26.2.2021
12. The incidence of brain metastases among patients with metastatic breast cancer

    Vom: 12.2.2021
13. Epidemiology of Brainstem High-Grade Gliomas in Children and Adolescents in the United States, 2000-2017

    Vom: 29.1.2021
14. A large longitudinal study of patients with Neurofibromatosis Type 2.

    Vom: 15.1.2021
15. Vorinostat and bevacizumab for recurrent glioblastoma

    Vom: 1.1.2021
16. A subset of pediatric thalamic gliomas

    Vom: 18.12.2020
17. Supratotal resection of lower-grade gliomas

    Vom: 4.12.2020
18. Friends of SNO

    Vom: 20.11.2020
19. Announcing Neuro-Oncology: The Podcast

    Vom: 19.11.2020